| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Jan 24, 2025 | Keros Therapeutics, Inc. | CFO | Sell | 5.0 | -40,000 | -100.00% | ✓ | $1.8M |
| Nov 4, 2023 | Jan 8, 2024 | Keros Therapeutics, Inc. | CFO | Sell | 5.0 | -40,000 | -100.00% | ✓ | $1.8M |
| Jun 8, 2023 | Jun 12, 2023 | Keros Therapeutics, Inc. | CFO | Sell | 5.0 | -40,000 | -81.16% | ✓ | $1.9M |
| Feb 19, 2019 | Feb 21, 2019 | Wave Life Sciences Ltd. | CFO | Sell | 32.5 | -1,298 | -7.64% | ✓ | $47.8K |
| Sep 24, 2018 | Sep 26, 2018 | Wave Life Sciences Ltd. | CFO | Sell | 5.0 | -29,500 | -63.46% | ✓ | $1.6M |
| Feb 16, 2018 | Feb 21, 2018 | Wave Life Sciences Ltd. | CFO | Sell | 48.8 | -316 | -1.83% | ✓ | $16.4K |